Phoenix Sponsor Limited

1 deals · 0 closed · 0 liquidated · 1 in flight

Phoenix Sponsor Limited is the sponsor entity behind Phoenix Biotech Acquisition Corp (Nasdaq: PBAX), a blank-check company that completed its initial public offering in 2021 targeting the biotechnology and life sciences sector. The vehicle sought to identify and merge with a high-growth biotech business, reflecting a wave of healthcare-focused SPACs that came to market during that period. As of the latest available data, the sponsor has one SPAC to its record with no completed business combination and no liquidation on file, leaving its deal status unresolved. Investors and analysts tracking this sponsor's progress can access the full filing history, deal timeline, and status updates on SpacDesk — sign up today for complete data coverage.

Hot Seat Score

—Insufficient history

Close rate

—

Median speed

—

Blended redemption

—

Total votes / extensions

0 / 0

Composite score combining historical close rate, median speed to deal close, and blended redemption discipline across all SPACs this sponsor has run. Higher score = institutional reputation worth retaining. Updates as new vote / closing data lands.

Win Rate (settled)

—

Total IPO Capital

$60.0M

Avg Extensions / Deal

0.0

Canonical

phoenix sponsor

Promote Economics (1 SPAC with data)

Total At-Risk

$3.8M

Total PP Warrants

380,000

Principals (5)

Wayne Christopher FarmerDirector

Pak Ying MakDirector and Chief Financial Officer

Ichi ShihIndependent Director

Cheng PengIndependent Director

Jun Chih KingIndependent Director

SPACs sponsored

Symbol	Issuer	IPO	IPO Size	Status	Target	Outcome	Extensions
PHEX	Phoenix Acquisition Ltd	—	$60.0M	Withdrawn	—	—	0